Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Zuranolone by Sage Therapeutics for Treatment Resistant Depression: Likelihood of Approval
Zuranolone is under clinical development by Sage Therapeutics and currently in Phase II for Treatment Resistant Depression. According to GlobalData,...
Data Insights
Zuranolone by Sage Therapeutics for Generalized Anxiety Disorder (GAD): Likelihood of Approval
Zuranolone is under clinical development by Sage Therapeutics and currently in Phase II for Generalized Anxiety Disorder (GAD). According to...